| Overview |
| bs-53045R |
| TAF1 Polyclonal Antibody |
| WB, IHC-P |
| Human, Mouse, Rat |
| Specifications |
| Unconjugated |
| Rabbit |
| Polyclonal antibody raised in rabbit against TAF1 using a KLH-conjugated synthetic peptide. |
| Polyclonal |
| #REF! |
| Not Determined |
| 1.15_g/_l |
| Affinity purification |
| 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20C for 12 months. |
| Target |
| 6872 |
| P21675 |
| TAFII250, p250, BA2R, CCG1, CCGS, TAF2A, KAT4, NSCL2, DYT3 |
| Largest component and core scaffold of the TFIID basal transcription factor complex (PubMed:25412659, PubMed:27007846). Contains novel N- and C-terminal Ser/Thr kinase domains which can autophosphorylate or transphosphorylate other transcription factors. Phosphorylates TP53 on 'Thr-55' which leads to MDM2-mediated degradation of TP53. Phosphorylates GTF2A1 and GTF2F1 on Ser residues. Possesses DNA-binding activity (PubMed:25412659). Essential for progression of the G1 phase of the cell cycle (PubMed:11278496, PubMed:15053879, PubMed:2038334, PubMed:8450888, PubMed:8625415, PubMed:9660973, PubMed:9858607). Exhibits histone acetyltransferase activity towards histones H3 and H4 (PubMed:15870300). |
| Application Dilution |
| WB |
1:300-5000 |
| IHC-P |
1:200-400 |